EG 427 is a Biotech company based in Paris, France. It has raised $55M in total funding.
EG 427 funding overview
EG 427 is a Biotech company based in Paris, France. EG 427 has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. The round record for EG 427 runs through 2025; nothing later has been disclosed. Investors on record include Andera Partners, Bpifrance Life Sciences Venture, SCI Ventures, Cohesion Bureau, David Lamond. 5 distinct backers are named across the disclosed rounds.
EG 427 at a glance
Total raised
$55M
Latest round date
February 2025
Industry
Biotech
Headquarters
Paris, France
Notable investors
Andera Partners, Bpifrance Life Sciences Venture, SCI Ventures, Cohesion Bureau, David Lamond
Frequently asked about EG 427 funding
How much has EG 427 raised?
EG 427 has raised $55M in total disclosed funding across the rounds on record.
Who has invested in EG 427?
Andera Partners, Bpifrance Life Sciences Venture, SCI Ventures, Cohesion Bureau, David Lamond are named among the investors backing EG 427.
What was the latest EG 427 funding round?
No round stage has been disclosed for EG 427.
Where is EG 427 based?
EG 427 is based in Paris, France.
What sector does EG 427 operate in?
EG 427 is tracked under Biotech from Paris, France, with $55M in disclosed funding.
When did EG 427 last raise?
The last disclosed EG 427 round closed in February 2025.
We update the EG 427 record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Paris and their backers are listed below.
